Stories from MedEsthetics

Business Education for Medical Practitioners
Visit us at medestheticsmagazine.com
Monday, May 4, 2015 - 11:02
Main Image: NeoStrata Sheer Physical Protection SPF 50 mineral sunscreen offers antiaging benefits in addition to broad spectrum UVA/UVB protection. Gluconolactone and lactobionic acid preserve the skin matrix and smooth the skin; EGCG (green tea extract) and vitamin E fight against oxidative damage and protect cellular DNA; while titanium dioxide and zinc oxide provide protection from UV rays. Contact: 800.628.9904, www.neostratapro.com. No, don't share this with BeautyEtcArticles: ProductsArticle free tagging: skin careNeoStrataSheer Physical ProtectionSPF 50
http://medestheticsmag.com/sheer-protection
Monday, May 4, 2015 - 10:54
Main Image: Noncomedogenic and paraben-free EltaMD Barrier Renewal Complex moisturizes the stratum corneum to improve dry or compromised skin and promote a healthy skin barrier. The daily-use complex includes a blend of ceramides and essential lipids plus enzymes and vitamins to reduce inflammation, promote cell turnover, minimize the appearance of fine lines and wrinkles, and improve skin texture, tone and pore size. Contact: 800.633.8872, www.eltamd.com. No, don't share this with BeautyEtcArticles: ProductsArticle free tagging: skin careEltaMDBarrier Renewal Complex
http://medestheticsmag.com/barrier-repair-support
Thursday, April 30, 2015 - 14:11
Deck: Byline: Main Image: KYBELLA injection (deoxycholic acid, KYTHERA Biopharmaceutcials), also known as ATX-101, has been FDA approved for contouring moderate to severe convexity or fullness associated with submental fat in adults. KYBELLA is a nonhuman and non-animal formulation of deoxycholic acid that aids in the breakdown and absorption of dietary fat. When injected into subcutaneous fat, the drug destroys fat cells. The approval was based on the results of over 20 clinical studies involving more than 2,600 male and female patients. No, don't share this with...
http://medestheticsmag.com/kybella-injectable-approved-double-chin
Thursday, April 30, 2015 - 14:07
Deck: Byline: The American Academy of Cosmetic Surgery (AACS) is re-establishing its Facial Fellowship Programs and General Cosmetic Surgery Fellowship Programs, which qualify fellow candidates to sit for the facial cosmetic surgery board exam. The AACS is accepting applications for both fellowship directors—to qualify, you must be a Diplomate of the American Board of Cosmetic Surgery (ABCS) as well as a current fellow-level member of the AACS—and fellowship trainees. For more information, visit www.cosmeticsurgery.org. No, don't share this with BeautyEtcArticle free tagging: ...
http://medestheticsmag.com/aacs-reinstitutes-fellowship-programs
Thursday, April 30, 2015 - 14:03
Main Image: In addition to aesthetic improvement, patients who undergo facial rejuvenation procedures are perceived as more likeable, more feminine and more socially skilled. Michael J. Reilly, MD, et al, performed a retrospective evaluation of preoperative and postoperative photos of 30 caucasian female patients who underwent facial rejuvenation surgery between January 1, 2009, and December 31, 2013. The procedures performed included facelift, blepharoplasty, eyebrow lift, neck lift and/or chin implant.No, don't share this with BeautyEtcArticles: ArticlesNewsArticle free tagging:...
http://medestheticsmag.com/aesthetic-facial-surgery-makes-patients-more-likeable
Thursday, April 23, 2015 - 15:47
Deck: Byline: Main Image: The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Samcyprone (RXi Pharmaceuticals) for the treatment of cutaneous metastases associated with malignant melanoma stage IIb to IV. It’s also being clinically investigated for the treatment of warts and alopecia areata. No, don't share this with BeautyEtcArticles: Skin CareNewsArticle free tagging: RXi PharmaceuticalsmelanomaSamcyprone
http://medestheticsmag.com/samcyprone-receives-orphan-drug-status-melanoma-treatment
Thursday, April 23, 2015 - 15:41
Deck: Byline: Main Image: The American Society for Dermatologic Surgery (ASDS) is setting up two memorial funds to honor the late Frederic S. Brandt, MD, an ASDS member for over 30 years who passed away earlier this month. The funds will provide opportunities for ASDS members, industry and interested donors to support the field of cosmetic dermatology that Dr. Brandt held dear.No, don't share this with BeautyEtcArticles: ArticlesNewsArticle free tagging: ASDSFrederic Brandt MDFellowship Program
http://medestheticsmag.com/asds-establishes-memorial-funds-and-accepts-applications-cosmetic-fellowship-program
Thursday, April 23, 2015 - 15:34
Deck: Byline: DEKA Medical, developer and distributor of light-based aesthetics systems, has received additional Food and Drug Administration (FDA) clearance for its Synchro REPLA:Y family of three laser platforms, allowing for a maximum power of 180W and a 24mm spot size, the largest currently available.No, don't share this with BeautyEtcArticle free tagging: DEKA MedicalSynchro REPLA:YlasersArticles: EquipmentNews
http://medestheticsmag.com/synchro-replay-laser-systems-cleared-higher-fluence-and-larger-spot-size
Thursday, April 16, 2015 - 13:00
Deck: Byline: Main Image: Specialty pharmaceutical company Neothetics will begin two Phase 3 trials—AbCONTOUR1 and AbCONTOUR2—of LIPO-202, the first noninvasive drug candidate for the reduction of central abdominal bulging due to subcutaneous fat in non-obese subjects. LIPO-202 is an injectable formulation of salmeterol xinafoate, a long-acting ß2-adrenergic receptor agonist that activates ß2-adrenergic receptors on fat cells, triggering the breakdown of triglycerides stored in the cells and causing lipolysis. Previous studies have indicated that LIPO-202 safely and effectively...
http://medestheticsmag.com/neothetics-initiates-phase-3-trials-abdominal-fat-reducing-injectable
Thursday, April 16, 2015 - 12:55
Deck: Byline: Cipher Pharmaceuticals has acquired INNOCUTIS, a privately held specialty dermatology company, for $45.5 million in cash. The agreement also includes additional INNOCUTIS management incentive payments of up to $3 million in cash over a three-year period based on the achievement of certain financial performance targets. No, don't share this with BeautyEtcArticle free tagging: Cipher PharmaceuticalsINNOCUTISArticles: News
http://medestheticsmag.com/cipher-acquires-innocutis
Thursday, April 16, 2015 - 12:53
Deck: Byline: The Society for Investigative Dermatology (SID) has entered into a publishing agreement with Elsevier, a provider of scientific, medical and technical information products and services. Elsevier will publish the Journal of Investigative Dermatology (JID)—the official journal of the SID and the European Society for Dermatological Research (ESDR)—starting in January 2016. No, don't share this with BeautyEtcArticle free tagging: ElsevierJournal of Investigative DermatologyArticles: News
http://medestheticsmag.com/elsevier-publish-jid
Wednesday, April 15, 2015 - 14:59
Deck: Camp Wonder and the CSDF allow children with dermatologic diseases to leave their conditions behind and just be kids for one week each year.Byline: By Laura BelizMain Image: When she was 11 years old, Francesca Tenconi was diagnosed with pemphigus foliaceus and began receiving treatment for her potentially fatal skin condition at a number of university hospitals. There, she met other children suffering from skin disease and commiserated with the unique problems they all had to face. For her 16th birthday, Tenconi asked for donations to create an organization for kids with...
http://medestheticsmag.com/comfortable-their-skin
Friday, April 10, 2015 - 10:57
http://medestheticsmag.com/advertise-form
Thursday, April 9, 2015 - 16:23
Main Image: In a study published in Plastic and Reconstructive Surgery (April 2015), two approaches to fat grafting for facial rejuvenation were found to have similar antiaging effects. No, don't share this with BeautyEtcArticles: Skin CareNewsArticle free tagging: Stem cellsfat graftsstromal vascular fraction
http://medestheticsmag.com/different-types-facial-fat-grafts-yield-similar-results
Thursday, April 9, 2015 - 16:20
Deck: Byline: When comparing the efficacy and tolerability of a fixed combination clindamycin (1.2%) and benzoyl peroxide (3.75%) aqueous gel for facial acne, researcher Julie C. Harper, MD, found that females treated with the gel experienced a greater reduction in acne lesions than males. In addition, a greater number of female subjects achieved a 2-grade reduction in acne severity. The multicenter, double-blind, vehicle-controlled, 12-week, 2-arm study (Journal of Drugs in Dermatology, April 2015) included 498 patients with moderate to severe acne vulgaris.No, don't share this...
http://medestheticsmag.com/acne-treatment-efficacy-varies-gender
Thursday, April 9, 2015 - 16:15
Deck: Byline: Jamie Altman, MD, owner of Aesthetic Dermatology Associates, PC, in Philadelphia, has launched www.acnecaremd.com, a secure telemedicine website designed to provide acne care to patients across Pennsylvania via a web-based platform. The site was designed to offer patients direct access to physicians when needed and to help ensure better compliance with treatment plans.No, don't share this with BeautyEtcArticle free tagging: telemedicineacneArticles: Skin CareNews
http://medestheticsmag.com/dermatologist-launches-telemedicine-website-acne-patients
Monday, April 6, 2015 - 12:44
http://medestheticsmag.com/most-innovative-marketing-campaign
Monday, April 6, 2015 - 12:39
http://medestheticsmag.com/happiest-employees

Pages

Advertisement - Box 1

Advertisement - Box 2

Advertisement - Box 3

Advertisement - Box 4

Advertisement - Box 5

Advertisement - Box 6